What Silicon Laboratories (SLAB)'s Launch of PSA Level 4 IoT SoCs Means for Shareholders

• Silicon Labs recently announced the general availability of its Series 3 platform SoCs, the SiMG301 and SiBG301, which deliver advanced compute, connectivity, and security features for IoT edge devices and are now shipping globally.
• The SiMG301 is one of the first devices to earn Matter Compliant Platform Certification and, together with the Series 3 Secure Vault, achieves the world's first PSA Level 4 security certification, potentially streamlining regulatory compliance and accelerating device certification in the growing IoT market.
• We'll examine how the debut of PSA Level 4 certified SoCs could impact Silicon Labs' outlook in secure IoT connectivity solutions.

This technology could replace computers: discover 26 stocks that are working to make quantum computing a reality.

Silicon Laboratories Investment Narrative Recap

Investors in Silicon Laboratories are typically betting on the rapid expansion of secure, wireless IoT solutions as a catalyst for both revenue growth and margin expansion. The recent rollout of Series 3 SoCs with PSA Level 4 security and Matter certification addresses a key short-term catalyst, gaining share in connected device markets requiring advanced security. However, industry commoditization and pricing pressure from larger rivals still represent a significant risk to margins; this launch may not meaningfully offset those pressures in the near term.

Among recent developments, the August 4 announcement of Series 3 Secure Vault achieving PSA Level 4 certification stands out. This aligns directly with regulatory trends and strengthens Silicon Labs' differentiation, potentially supporting the company's ability to secure premium customer projects as security requirements intensify.

But while these security credentials can set Silicon Labs apart, investors should also know the potential impact from...

Read the full narrative on Silicon Laboratories (it's free!)

Silicon Laboratories is projected to achieve $1.2 billion in revenue and $13.9 million in earnings by 2028. This outlook is based on an expected annual revenue growth rate of 19.2% and a $118.5 million increase in earnings from the current level of -$104.6 million.

Uncover how Silicon Laboratories' forecasts yield a $150.44 fair value, a 12% upside to its current price.

Exploring Other Perspectives

Simply Wall St Community users offered two fair value targets for SLAB, ranging from US$79.35 to US$150.44. While product innovation has boosted differentiation, looming competition and industry commoditization still influence market outlooks, so weigh multiple opinions before making a call.

Explore 2 other fair value estimates on Silicon Laboratories - why the stock might be worth 41% less than the current price!

Build Your Own Silicon Laboratories Narrative

Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.

• A great starting point for your Silicon Laboratories research is our analysis highlighting 1 key reward that could impact your investment decision.
• Our free Silicon Laboratories research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Silicon Laboratories' overall financial health at a glance.

No Opportunity In Silicon Laboratories?

Opportunities like this don't last. These are today's most promising picks. Check them out now:

• The latest GPUs need a type of rare earth metal called Dysprosium and there are only 32 companies in the world exploring or producing it. Find the list for free.
• AI is about to change healthcare. These 31 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Trump has pledged to "unleash" American oil and gas and these 22 US stocks have developments that are poised to benefit.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com